Latest Biotech Startup Funding Rounds

Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.

This page showsSector: Biotech
Rounds
603
All time
Disclosed funding
$28.7B
480 disclosed amounts
Median round
$17M
Of disclosed amounts
603 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
Neela BiotechClimate tech · United KingdomCompany profile

Neela Biotech develops microbial processes that turn organic waste into feedstocks for sustainable aviation fuel.

Neela Biotech develops microbial processes that turn organic waste into feedstocks for sustainable aviation fuel.

UndisclosedGrowth Catalyst grantUndisclosedBiotech, Climate techUnited KingdomInvestors
Coherence NeuroHealthtech · United StatesCompany profile

Investigational implants and bioelectronic systems for monitoring and treating cancer.

Investigational implants and bioelectronic systems for monitoring and treating cancer.

$10MSeedBiotech, HealthtechUnited StatesInvestors
Kailera TherapeuticsBiotech · United StatesCompany profile

Kailera Therapeutics develops oral and injectable medicines for obesity using several GLP-1-based mechanisms.

Kailera Therapeutics develops oral and injectable medicines for obesity using several GLP-1-based mechanisms.

$600MSeries BBiotechUnited StatesInvestors
KardiganBiotech · United StatesCompany profile

Kardigan develops cardiovascular medicines that target specific biological drivers of heart disease and the patient groups most likely to respond.

Kardigan develops cardiovascular medicines that target specific biological drivers of heart disease and the patient groups most likely to respond.

$254MSeries BBiotechUnited StatesInvestors
Surv BioPharmaBiotech · JapanCompany profile

Surv BioPharma develops oncolytic virus therapies for cancer.

Surv BioPharma develops oncolytic virus therapies for cancer.

¥1.5BSeries B first closeSeries BBiotechJapanInvestors
FELIQSBiotech · JapanCompany profile

FELIQS develops small-molecule medicines for retinal diseases.

FELIQS develops small-molecule medicines for retinal diseases.

$10MSeries A total including extensionSeries ABiotechJapanInvestors
AmytisEnterprise software · United KingdomCompany profile

Amytis builds an AI-assisted workspace for life science researchers, connecting experiment planning, laboratory records, literature and data analysis.

Amytis builds an AI-assisted workspace for life science researchers, connecting experiment planning, laboratory records, literature and data analysis.

£60KAccelerator investmentUndisclosedBiotech, Enterprise softwareUnited KingdomInvestors
TimeTellerHealthtech · GermanyCompany profile

Saliva-based diagnostics that measure a person’s circadian rhythm.

Saliva-based diagnostics that measure a person’s circadian rhythm.

Undisclosedcapacura investmentUndisclosedBiotech, HealthtechGermanyInvestors
Beeline MedicinesBiotech · United StatesCompany profile

Beeline Medicines develops clinical-stage therapies that target immune dysfunction in lupus and other autoimmune and inflammatory diseases.

Beeline Medicines develops clinical-stage therapies that target immune dysfunction in lupus and other autoimmune and inflammatory diseases.

$300MSeries ABiotechUnited StatesInvestors
LABTECHSBiotech · JapanCompany profile

LABTECHS develops rapid sterility testing kits and reagents from research at the University of Toyama.

LABTECHS develops rapid sterility testing kits and reagents from research at the University of Toyama.

UndisclosedGo-Tech research grant selectionUndisclosedBiotechJapanInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    RA Capital Management

    Delix Therapeutics, Alethio Therapeutics, Estuary Biotherapeutics

    27rounds
    6led
  2. 2
    Eli Lilly and Company

    Oyster Therapeutics, BigHat Biosciences, Circle Pharma, Inc.

    16rounds
    0led
  3. 3
    Janus Henderson Investors

    Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics

    16rounds
    1led
  4. 4
    ARCH Venture Partners

    Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences

    16rounds
    1led
  5. 5
    OrbiMed

    Dren Bio, Star Therapeutics, Leal Therapeutics

    12rounds
    1led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic